Group 1 - The core point of the article is that Haisen Pharmaceutical has been recognized as a national-level "specialized, refined, distinctive, and innovative" small giant enterprise by the Ministry of Industry and Information Technology, which enhances the company's brand recognition and industry influence [1] - Haisen Pharmaceutical was previously recognized as a specialized and innovative small enterprise in Zhejiang Province in 2021, indicating a consistent track record of innovation and capability [1] - The company's revenue composition for the first half of 2025 is entirely from the pharmaceutical manufacturing industry, indicating a focused business model [1] Group 2 - As of the report, Haisen Pharmaceutical has a market capitalization of 3.3 billion yuan [2]
海森药业：公司通过第七批专精特新“小巨人”企业认定